The British Medical Journal today raised more questions about whether diabetes drug Avandia should ever have been approved for patients in the United States and Europe, and whether the drug “may be about to fold.”

Dr. Steven Nissen, the Cleveland Clinic’s high-profile cardiovascular medicine chair, is staking his reputation as a drug-safety advocate on a shortened regulatory pathway for a cholesterol-fighting drug made by a Swedish company, according to a report in the May 31 issue of Bloomberg Businessweek.Nissen is interested in eprotirome, developed by Karo Bio AB, because in [...]

Two years after emerging as an independent with aspirations to become one of the nation’s top hospitals, Christ Hospital in Mount Auburn hopes to spend hundreds of millions of dollars in the next decade, recruit more than 200 doctors to Greater Cincinnati and build a network of about five ambulatory centers around the region, according to the Cincinnati Enquirer.

CNN’s State of the Union host and chief national correspondent John King went inside the Cleveland Clinic for online and broadcast reports on the next generation of health care in America.

Nissen is a bit fire-and-brimstone when speaking to the public about the U.S. Food and Drug Administration. But Thursday afternoon, he was standing in front of fellow cardiologists — as well as drug and medical device companies — during a lunch speech at the Clinic’s three-day symposium on cardiovascular care.

A decision on the nominee for U.S. Food and Drug Administration commissioner was expected this week, and it seemed increasingly likely that the Cleveland Clinic’s Dr. Steven Nissen would not get the nod. Then Tom Daschle withdrew as Health and Human Services nominee, calling into question what could happen at the FDA.

Health science is big business. And Battelle, the Columbus research institution, is involved in health science in a big way, according to the Columbus Dispatch.

Dr. Steven Nissen: The FDA is a failed agency that the public should not trust.